Grover's disease successfully treated with calcipotriene/betamethasone dipropionate ointment.

Dermatol Ther

Department of Dermatology, Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan.

Published: November 2020

Download full-text PDF

Source
http://dx.doi.org/10.1111/dth.14217DOI Listing

Publication Analysis

Top Keywords

grover's disease
4
disease treated
4
treated calcipotriene/betamethasone
4
calcipotriene/betamethasone dipropionate
4
dipropionate ointment
4
grover's
1
treated
1
calcipotriene/betamethasone
1
dipropionate
1
ointment
1

Similar Publications

Article Synopsis
  • Grover disease is a skin condition characterized by blistering caused by the breakdown of connections between skin cells, with its causes still unknown and no FDA-approved treatment available.
  • Research has shown that B-RAF inhibitors used in cancer treatment can paradoxically lead to Grover disease by causing hyperactivation of ERK, which disrupts skin cell cohesion.
  • The study suggests that inhibiting MEK can prevent the onset of Grover disease by controlling ERK activation, indicating a potential therapeutic approach that could benefit both Grover disease and similar genetic conditions like Darier disease.
View Article and Find Full Text PDF
Article Synopsis
  • The article DOI: 10.1177/2475530320970530 has been amended to address inaccuracies or errors found in the original work.
  • The corrections made aim to improve the clarity and credibility of the information presented.
  • Readers are encouraged to refer to the updated article for the most accurate and reliable content.
View Article and Find Full Text PDF
Article Synopsis
  • * There is a noted but poorly defined connection between GD and cutaneous keratinocyte carcinomas, specifically non-melanoma skin cancers (NMSCs), with very few studies highlighting this relationship between 1983 and 2024.
  • * GD has been misdiagnosed as various NMSCs, and understanding this connection could provide insights into its underlying mechanisms, possibly reclassifying GD as a unique syndrome.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!